Radiation Oncology News

How we're using high-dose radiation therapy to treat kidney cancer

How we're using high-dose radiation therapy to treat kidney cancer

It’s true that kidney cancer doesn’t respond well to conventional, low-dose per treatment radiation therapies. But we’ve found that the disease is sensitive to a type of high-dose per treatment radiation therapy known as stereotactic radiotherapy.

New Study Shows Breast Cancer Death Rate Drops Nearly 40 Percent Over A 25-Year Period

New Study Shows Breast Cancer Death Rate Drops Nearly 40 Percent Over A 25-Year Period

New Study Shows Breast Cancer Death Rate Drops Nearly 40 Percent Over A 25-Year Period

Dr. Larry Kun - 2017 Memphis Business Journal Health Care Heroes Lifetime Achievement honoree

Dr. Larry Kun - 2017 Memphis Business Journal Health Care Heroes Lifetime Achievement honoree

Dr. Larry Kun is this year’s Memphis Business Journal Health Care Heroes Lifetime Achievement honoree for his 32 years of commitment and innovation at St. Jude Children’s Research Hospital. He joined St. Jude in 1984 to help establish a radiation therapy team that specialized in treating childhood cancer. Under his leadership, that program became one of the country’s most successful pediatric brain tumor programs. In 2013, he was appointed to Clinical Director and Executive Vice President. In 2016, Dr. Kun left St. Jude for Dallas to be closer to family. Soon after, he joined UT Southwestern as Professor and Director of Educational Programs for Radiation Oncology and Professor for Pediatrics.

UTSW receives national recognition

UTSW receives national recognition

U.S. News & World Report just released its 2017 list of top hospitals. UT Southwestern ranks #1 in the Dallas/Ft. Worth area and #2 in Texas. In addition, we nationally ranked in six specialties and are noted as high-performing in four conditions, including cancer. An honor to be recognized!

For this cancer patient, hope comes without chemo

For this cancer patient, hope comes without chemo

According to the American Brain Tumor Association, there are nearly 700,000 people in the U.S. living with a primary brain and central nervous system tumor, and nearly 17,000 this year will die from it. Glioblastoma represents 14.9 percent of all primary brain tumors and has the highest number of cases of malignant tumors with an estimated 12,390 new cases predicted in 2017.

Combo immunotherapy may herald new standard of care for kidney cancer

Combo immunotherapy may herald new standard of care for kidney cancer

Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20 percent to 40 percent, a new study shows.

UT Southwestern Cancer Center Only Texas Site Selected For Clinical Trial

UT Southwestern Cancer Center Only Texas Site Selected For Clinical Trial

Dallas-based UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center is the only site in Texas selected for a national cancer clinical trial. The Cancer Moonshot trial will focus on finding personal approaches to treat one type of blood cancer.

A new chapter in radiation oncology

A new chapter in radiation oncology

UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center is one of the nation’s top destinations for patients seeking cancer treatments. Now it has a new radiation oncology building to call home that’s as sterling as its reputation.

Strategy of Hope: Patients try creative approaches to fight brain cancer

Strategy of Hope: Patients try creative approaches to fight brain cancer

Dennis and Candace Kothmann, married for 26 years, are hoping a new approach to fighting brain cancer can extend or save Dennis’ life. Mr. Kothmann was diagnosed last fall with glioblastoma, the deadliest form of primary brain cancer.

Study: New approach to destroying deadly brain tumors

Study: New approach to destroying deadly brain tumors

A new strategy for treating brain tumors may extend or save the lives of patients diagnosed with one of the deadliest forms of cancer, according to a study from UT Southwestern Medical Center.

UT Southwestern Findings Show Stereotactic Radiation Reduces Treatment Time

UT Southwestern Findings Show Stereotactic Radiation Reduces Treatment Time

UT Southwestern Medical Center researchers recently discovered a new way to reduce breast cancer treatment time. They found that stereotactic partial breast radiation, a non-invasive form of radiation treatment, is just as safe and effective as traditional practices, and only takes days to complete. Currently, UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center is the only medical center in Texas to offer stereotactic partial breast radiation treatment to early-stage patients.

Introducing a new, faster treatment for early-stage breast cancer

Introducing a new, faster treatment for early-stage breast cancer

UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center is the only site in Texas and among only a few in the world to offer this new treatment to early-stage breast cancer patients. Stereotactic partial-breast radiation is delivered with the latest-generation Cyberknife, one of several technologies housed in UT Southwestern’s newly opened Radiation Oncology facility.

High-tech radiation oncology building opens its doors

High-tech radiation oncology building opens its doors

UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center is one of the nation’s top destinations for patients seeking cancer treatments. Now it has a new radiation oncology building to call home that’s as sterling as its reputation.

UTSW first in Texas to premiere latest Gamma Knife Icon technology

UTSW first in Texas to premiere latest Gamma Knife Icon technology

UT Southwestern is paving the way for safer and more convenient radiation treatments for brain tumor patients. Doctors are using a new cutting-edge tool that combines precision treatment and increased protection, without the need for halo-style head restraints.

Researchers uncover mechanism for cancer-killing properties of pepper plant

Researchers uncover mechanism for cancer-killing properties of pepper plant

UT Southwestern Medical Center scientists have uncovered the chemical process behind anti-cancer properties of a spicy Indian pepper plant called the long pepper, whose suspected medicinal properties date back thousands of years.

First Gamma Knife Icon in Texas allows frameless treatment option for brain cancer and metastases

First Gamma Knife Icon in Texas allows frameless treatment option for brain cancer and metastases

The new Gamma Knife “Icon” being installed this month at the Annette Simmons Stereotactic Treatment Center at Zale Lipshy University Hospital will be the first in Texas to allow stereotactic radiosurgery without placement of a head frame.

Cancer investigators receive major donor-funded grants for combined immunotherapy and radiation research

Cancer investigators receive major donor-funded grants for combined immunotherapy and radiation research

Neil Desai, M.D., Ph.D., Assistant Professor of Radiation Oncology, has been appointed a Dedman Family Scholar in Clinical Care, an honor that comes with a $600,000, four-year grant. Two other physician-led grants were awarded by the Lupe Murchison Foundation and the Once Upon a Time Foundation.

Role for SABR in metastatic renal cell cancer

Role for SABR in metastatic renal cell cancer

Dr. Raquibul Hannan is interviewed on Cancer Network about stereotactic ablative radiotherapy (SABR) for advanced kidney cancer.

Dr. Iyengar on the rationale for treating stage 3 lung cancer with hypofractionated radiation

Dr. Iyengar on the rationale for treating stage 3 lung cancer with hypofractionated radiation

In an interview with OncLive, Puneeth Iyengar, M.D., Ph.D., Assistant Professor of Radiation Oncology, explains why dividing the prescribed radiation dose into fewer treatments, with a higher amount of dosage given in each treatment ("hypofractionation"), may benefit patients.

New faculty members and promotions in Radiation Oncology

New faculty members and promotions in Radiation Oncology

Andrei Pugachev, Ph.D., is a new Assistant Professor in our Physics Division, while Heeyoun Bunch, Ph.D., joins the Molecular Radiation Biology Division as an Instructor.

New laboratory opens under Davis

New laboratory opens under Davis

Assistant Professor Tony Davis, Ph.D., has been made an independent in­vestigator in the department’s Division of Molecular Radiation Biology.

Physician joins head and neck cancer team

Physician joins head and neck cancer team

Nhat-Long Pham, M.D., Ph.D., has joined UT Southwestern Radiation Oncology as Assistant Professor and member of the team treating head and neck cancer.

Designs on ultrasound-guided radiotherapy

Designs on ultrasound-guided radiotherapy

Ultrasound imaging provides marker-free, soft-tissue visualization, without exposing the patient to any extra radiation dose. As such, several research groups are investigating the use of ultrasound guidance for localizing soft-tissue structures and tumors during radiotherapy. Research in UT Southwestern's Division of Medical Physics and Engineering is highlighted online today in an article on medicalphysicsweb.

Radiation Oncology well-represented at ASTRO

Radiation Oncology well-represented at ASTRO

With 16 abstracts, seven presentations, and one press briefing, the faculty of UT Southwestern Radiation Oncology will be well-represented at the 50th annual conference of the American Society for Radiation Oncology (ASTRO).

Neutrophils are key to harnessing anti-tumor immune response from radiation therapy, study finds

Neutrophils are key to harnessing anti-tumor immune response from radiation therapy, study finds

Combining targeted radiation therapy with a neutrophil stimulant enhances anti-tumor immunity, according to new research into cancer immunology at UT Southwestern Medical Center

Wardak added to physician team

Wardak added to physician team

Zabi Wardak, M.D., has been appointed Assistant Professor in the Department of Radiation Oncology, joining the team focused on treating central nervous system (CNS) cancer.

Residency program director named

Residency program director named

Michael Folkert, M.D., Ph.D., has been charged with leading the department’s Radiation Oncology Residency Program.

Jiang awarded $4m from CPRIT

Jiang awarded $4m from CPRIT

Dr. Steve Jiang, Professor and Vice Chair of Radiation Oncology and Chief of the Division of Medical Physics and Engineering, has been awarded $4 million by the Cancer Prevention and Research Institute of Texas (CPRIT) to develop new technology to treat lung cancer patients with heavy ions. A total of $9.6 million was awarded to UT Southwestern researchers by CPRIT in the latest round of funding.

Physicians join Radiation Oncology

Physicians join Radiation Oncology

The Department of Radiation Oncology welcomes two physicians this month to our growing team.

Grants awarded to Radiation Oncology researchers

Grants awarded to Radiation Oncology researchers

Grants totalling more than $2.6 million have been awarded to researchers in medical physics and molecular radiation biology.

Nathan Kim, M.D., Ph.D., joins Radiation Oncology

Nathan Kim, M.D., Ph.D., joins Radiation Oncology

Nathan Kim, M.D., Ph.D., has joined the faculty of UT Southwestern Radiation Oncology as Assistant Professor and member of the breast cancer team.

Speaker roundup for July

Speaker roundup for July

Department of Radiation Oncology faculty gave invited lectures at the following events recently:

Speaker roundup for June

Speaker roundup for June

Department of Radiation Oncology faculty gave invited lectures at the following events recently:

Texans want in on cancer "moonshot"

Texans want in on cancer "moonshot"

Our heavy ion initiative was highlighted during a national summit on cancer led by Vice President Joe Biden.

Desai joins Radiation Oncology leadership

Desai joins Radiation Oncology leadership

Kajal Desai, MPA, has joined the Department of Radiation Oncology as Department Administrator overseeing all the academic, financial and HR functions.

Have drug hunters finally cracked KRas?

Have drug hunters finally cracked KRas?

Assistant Professor Ken Westover, M.D., Ph.D., is featured in this article on developing cancer drugs to act against an elusive target.

Research shows 98% cure rate for prostate cancer using Stereotactic Body Radiation Therapy

Research shows 98% cure rate for prostate cancer using Stereotactic Body Radiation Therapy

A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) given in five sessions offers a higher cure rate for prostate cancer than more traditional approaches.

Department makes heavy ion grant awards

Department makes heavy ion grant awards

The Department of Radiation Oncology at UT Southwestern Medical Center has awarded five, two-year seed grants of $100,000 apiece to Texas researchers to facilitate research related to heavy ion therapy.

NASA awards funds to study effects of space radiation during Mars mission

NASA awards funds to study effects of space radiation during Mars mission

UT Southwestern Medical Center researchers have been awarded $3.6 million in NASA funds to study how space radiation would affect the cancer risk of astronauts taking part in deep space missions to Mars.

Surgery vs. SABR: "Stablemates" trial to directly compare treatment in operable cancer patients

Surgery vs. SABR: "Stablemates" trial to directly compare treatment in operable cancer patients

The results of a national trial evaluating stereotactic ablative radiotherapy (SABR) in lung cancer patients too frail to receive surgery were so positive that physicians have opened a multi-institutional trial to directly compare surgery vs. SABR in operable patients.

Physician discusses stereotactic combination therapy with WFAA/Ch 8

Physician discusses stereotactic combination therapy with WFAA/Ch 8

Dr. Robert Timmerman, Professor and Medical Director of Radiation Oncology, explains why treating cancer with a combination of stereotactic radiation and immunotherapy drugs is of increasing interest to researchers, in the wake of former president Jimmy Carter's cancer cure.

With CPRIT grants, new approaches for pediatric cancer treatment

With CPRIT grants, new approaches for pediatric cancer treatment

Investigators in the Department of Radiation Oncology were awarded close to $2.7 million in the latest round of funding from the Cancer Prevention and Research Institute of Texas (CPRIT) to study and treat childhood cancer.

Researchers develop classification model for cancers caused by most frequently mutated cancer gene

Researchers develop classification model for cancers caused by most frequently mutated cancer gene

UT Southwestern Medical Center researchers have developed a classification for cancers caused by KRAS, the most frequently mutated gene in cancer, that could eventually help oncologists choose more effective, customized cancer therapies.

Cancer researchers first in Texas to use new prostate rectal spacer to minimize side effects of SABR radiation treatments

Cancer researchers first in Texas to use new prostate rectal spacer to minimize side effects of SABR radiation treatments

UT Southwestern Medical Center cancer researchers are investigating whether an injectable, biodegradable gel can reduce potential side effects from extreme high-dose radiation treatments for prostate cancer.

Two physicians added to genitourinary team

Two physicians added to genitourinary team

Dr. Aaron Laine and Dr. Neil Desai are the newest clinical faculty members in Radiation Oncology.

New physician joins Radiation Oncology

New physician joins Radiation Oncology

We welcome the arrival this month of David Sher, M.D., M.P.H., as Associate Professor of Radiation Oncology and leader of the department’s head and neck team.

Westover featured in NCI blog

Westover featured in NCI blog

Ken Westover, M.D., Ph.D., writes about "The Enzymology of GTP-Competitive RAS Inhibitors" on the National Cancer Institute's RAS blog.

Physicians pioneer the use of stereotactic body radiation for deadly kidney cancer complication

Physicians pioneer the use of stereotactic body radiation for deadly kidney cancer complication

UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer. Read more.

CPRIT awards faculty $11.5 million for recruitment and research in brain and bone cancer, biology, and immunotherapy

CPRIT awards faculty $11.5 million for recruitment and research in brain and bone cancer, biology, and immunotherapy

UT Southwestern Medical Center researchers were awarded more than $7.5 million in research grants to improve diagnostic and therapeutic services and research relating to cancers of the brain, breast, throat, and bone, as well as to improve scientific understanding of cancer biology.

UTSW receives key NCI funding to plan first U.S. Center for Heavy Ion Radiation Therapy Research

UTSW receives key NCI funding to plan first U.S. Center for Heavy Ion Radiation Therapy Research

The National Cancer Institute (NCI) of the National Institutes of Health awarded UT Southwestern a $1 million planning grant to establish the country’s first National Center for Heavy Ion Radiation Therapy.

Resident wins top award at AMA Research Symposium

Resident wins top award at AMA Research Symposium

The American Medical Association selected Stephen G. Chun, M.D., a radiation oncology resident at UT Southwestern Medical Center, for its top award recognizing research from medicine’s brightest young minds.

Stereotactic body radiation therapy plus chemotherapy improves survival among stage 4 lung cancer patients

Stereotactic body radiation therapy plus chemotherapy improves survival among stage 4 lung cancer patients

A clinical trial that combined the two therapy regimens more than doubled survival rates for certain stage 4 lung cancer patients.

Cancer researchers identify irreversible inhibitor for KRAS gene mutation

Cancer researchers identify irreversible inhibitor for KRAS gene mutation

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

Video game processors to improve cancer patient care

Video game processors to improve cancer patient care

Medical physicists at UT Southwestern Medical Center are finding new ways to use the speed of video game processors to promote research that is aimed at improving patient care.

Blocking DNA repair could improve radiation therapy for brain cancer

Blocking DNA repair could improve radiation therapy for brain cancer

UT Southwestern Medical Center researchers have demonstrated in both cancer cell lines and in mice that blocking critical DNA repair mechanisms could improve the effectiveness of radiation therapy for highly fatal brain tumors called glioblastomas.

Possible world's first: Physicians use CyberKnife to treat vocal cord cancer

Possible world's first: Physicians use CyberKnife to treat vocal cord cancer

Stephen Wiley went from being a life-long cowboy to one of the world’s first patients to have vocal cord cancer treated by the CyberKnife, a robot that destroys tumors with highly precise doses of radiation.